Table 1. Characteristics of the breast cancer studies.
Sequencing | RPBCMS | MARIE cases | |
n | 50 | 296 | 2,715 |
Age at diagnosis (years) | 58.3±13.4 | 59.7±13.3 | 62.4±6.1 |
Percentage of premenopausal women | 31.3% | 34.3% | 9.2% |
Histology | |||
IDC | 74.0% | 75.0% | 66.3% |
ILC | 16.0% | 15.5% | 19.9% |
DCIS | 1.7% | 6.3% | |
other | 10.0% | 7.8% | 7.3% |
Tumour size | |||
with the diameter lessthan 2 cm | 54.0% | 58.0% | 51.5% |
with the diameter morethan 2 cm | 46.0% | 42.0% | 42.2% |
Tumour grade | |||
I | 4.0% | 8.0% | 17.4% |
II | 78.0% | 69.5% | 48.1% |
III | 18.0% | 22.5% | 28.1% |
Oestrogen receptor status | |||
positive | 84.0% | 86.3% | 79.0% |
negative | 16.0% | 13.7% | 21.0% |
Progesterone receptor status | |||
positive | 76.0% | 75.2% | 67.0% |
negative | 24.0% | 24.8% | 33.0% |
Notes: the age at diagnosis is indicated as mean value ± standard deviation.
Abbreviations:
IDC… infiltrative ductal carcinoma.
ILC… infiltrative lobular carcinoma.
DCIS… ductal carcinoma in situ.
RPBCMS… Risk Prediction of Breast Cancer Metastasis Study.